TGFB1 and neoplasm: The loss of canonical TGF-β/Smad signaling pathway initiates tumors; this phenomenon occurs because some tumor cells may escape the inhibitory effects of the canonical pathway through mutations that can provide a growth advantage over benign tumors.21